Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery

OBJECTIVES: To evaluate the efficacy and safety of 2.5 mg and 5 mg mifepristone during 3 months for the treatment of uterine fibroids before surgery. DESIGN: Multicenter randomized clinical trial. LOCATIONS: Eusebio Hernández Hospital, Havana, Cuba and the Alemán Hospital, Managua, Nicaragua. SUBJEC...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbonell Esteve, Josep L, Riverón, Ana M, Cano, Mariela, Ortiz, Alma I, Valle, Aleta, Texidó, Carlos S, Tomasi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310351/
https://www.ncbi.nlm.nih.gov/pubmed/22448109
http://dx.doi.org/10.2147/IJWH.S28103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310351/
https://www.ncbi.nlm.nih.gov/pubmed/22448109
http://dx.doi.org/10.2147/IJWH.S28103

Ejemplares similares